ReviewFrontiers in oncology2026

Late-phase strategies to overcome limitations of PD-1/PD-L1 therapy: a clinical development trajectory through 2030.

Elena A Andresyuk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.